ES2426017B1 - Microemulsion comprising collagenase and uses - Google Patents

Microemulsion comprising collagenase and uses Download PDF

Info

Publication number
ES2426017B1
ES2426017B1 ES201200340A ES201200340A ES2426017B1 ES 2426017 B1 ES2426017 B1 ES 2426017B1 ES 201200340 A ES201200340 A ES 201200340A ES 201200340 A ES201200340 A ES 201200340A ES 2426017 B1 ES2426017 B1 ES 2426017B1
Authority
ES
Spain
Prior art keywords
collagenase
microemulsion
recombinant
image
cellulite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201200340A
Other languages
Spanish (es)
Other versions
ES2426017R1 (en
ES2426017A2 (en
Inventor
Juan Ramón MUÑOZ MONTAÑO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteos Biotech SL
Original Assignee
Proteos Biotech SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteos Biotech SL filed Critical Proteos Biotech SL
Priority to ES201200340A priority Critical patent/ES2426017B1/en
Publication of ES2426017A2 publication Critical patent/ES2426017A2/en
Publication of ES2426017R1 publication Critical patent/ES2426017R1/en
Application granted granted Critical
Publication of ES2426017B1 publication Critical patent/ES2426017B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Microemulsión que comprenden colagenasa y usos.#Microemulsión de colagenasa G recombinante y colagenasa H recombinante, composiciones farmacéuticas y cosméticas, y su uso en el tratamiento de la celulitis.Microemulsion comprising collagenase and uses. # Microemulsion of recombinant collagenase G and recombinant collagenase H, pharmaceutical and cosmetic compositions, and their use in the treatment of cellulite.

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

imagen20image20

imagen21image21

imagen22image22

imagen23image23

imagen24image24

imagen25image25

imagen26image26

imagen27image27

imagen28image28

imagen29image29

imagen30image30

imagen31image31

imagen32image32

imagen33image33

imagen34image34

imagen35image35

imagen36image36

imagen37image37

imagen38image38

imagen39image39

imagen40image40

imagen41image41

imagen42image42

imagen43image43

imagen44image44

imagen45image45

imagen46image46

imagen47image47

imagen48image48

Claims (1)

imagen1image 1 imagen2image2 imagen3image3 imagen4image4
ES201200340A 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses Expired - Fee Related ES2426017B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201200340A ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201200340A ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Publications (3)

Publication Number Publication Date
ES2426017A2 ES2426017A2 (en) 2013-10-18
ES2426017R1 ES2426017R1 (en) 2013-11-27
ES2426017B1 true ES2426017B1 (en) 2014-09-17

Family

ID=49274128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201200340A Expired - Fee Related ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Country Status (1)

Country Link
ES (1) ES2426017B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
CN1579547A (en) * 2003-08-05 2005-02-16 上海乔源生物制药有限公司 Compound clostridiopeptidase compound emulsion and preparation method
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite

Also Published As

Publication number Publication date
ES2426017R1 (en) 2013-11-27
ES2426017A2 (en) 2013-10-18

Similar Documents

Publication Publication Date Title
ES2573524T3 (en) New anti-redness active ingredient and cosmetic compositions that comprise it
CR20150232A (en) IMIDAZO [1,2-A] PIRIDINCARBOXAMIDS AMINOSUSTITUIDAS AND ITS USE
CL2014003465A1 (en) Antibody that binds to the dimeric human epidermal growth factor receptor (hegfr); pharmaceutical composition comprising it; and use to treat cancer.
CL2015001702A1 (en) Tricyclic antiviral compounds; pharmaceutical composition; and use in the treatment of hepatitis c.
CL2014001829A1 (en) Compounds derived from indolizine; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer.
CL2015002733A1 (en) Pharmaceutical composition of s-ketamine hydrochloride.
CL2015000345A1 (en) Use of a combination for melanoma comprising the administration of cobimetinib and vemurafenib.
CL2014001047A1 (en) Heterocyclic compounds derived from pyrazine; composition and pharmaceutical combination that contain them and the use in respiratory and allergic diseases.
FR2998793B1 (en) COSMETIC COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION
CL2015001342A1 (en) Compounds derived from pyrrolo [3,2-d] pyrimidine; pharmaceutical and vaccine composition that comprises them and the use in the treatment of allergic diseases and other inflammatory, infectious and cancer diseases.
AR125920A2 (en) COMPOSITIONS COMPRISING VORTIOXETINE AND DONEPEZIL
DK2945642T3 (en) FACTOR 1 PROTEIN FOR USE IN THE TREATMENT OR PREVENTION OF DISEASE
BR112013003530A2 (en) '' pharmaceutical, kit, use and preparations ''
CL2012003322A1 (en) Compounds derived from substituted benzamide; pharmaceutical composition; and use in the treatment of cancer.
CL2014003525A1 (en) Pharmaceutical composition comprising fimasartan, hydrochlorothiazide and a binder; preparation procedure; its use in the treatment of hypertension.
CL2014003325A1 (en) Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease
CL2014003237A1 (en) Stable pharmaceutical formulation comprising an anti-dll4 antibody (human delta 4 ligand); and kit comprising the composition in a package and instructions.
FR3009956B1 (en) MOISTURIZING COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION; MOISTURIZING CARE PROCESS
CL2015001458A1 (en) Symbiotic composition and the use of it.
BR112014025416A2 (en) ANTIMALARIC AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THEM AND USE OF THE SAME.
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
CL2015000333A1 (en) Bir2 and / or bir3 inhibitor azaheterocycles; pharmaceutical composition; and use in the treatment of cancer.
CL2015000537A1 (en) Siarn and its use in methods and compositions for the treatment and / or prevention of eye diseases.
ES2609817T3 (en) Leukotoxin E / D as a new anti-inflammatory agent and microbicide
BR112015022154A2 (en) combinations of active substances, cosmetic or dermatological preparations, cosmetic use, and combinations of active substances and preparations

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2426017

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20140917

FD2A Announcement of lapse in spain

Effective date: 20210915